Annual Drug Patent Expirations for OFORTA
Oforta is a drug marketed by Sanofi Aventis Us and is included in one NDA. There is one patent protecting this drug.
This drug has thirty-six patent family members in thirty countries.
The generic ingredient in OFORTA is fludarabine phosphate. Additional details are available on the fludarabine phosphate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
